Literature DB >> 10702719

Human cytomegalovirus infection of immature dendritic cells and macrophages.

G Jahn1, S Stenglein, S Riegler, H Einsele, C Sinzger.   

Abstract

A central aspect of human cytomegalovirus (HCMV) pathogenesis is the interaction of the virus with different antigen-presenting cell (APC) types of the host. In principle, a number of various cell types have the potential of antigen presentation when MHC II expression is induced by appropriate stimuli. The most potent antigen presenters are monocytes/macrophages and dendritic cells (DCs), therefore called professional APCs. Interestingly, these cells seem to be targets of productive HCMV infection. The susceptibility of the monocyte/macrophage system has been analyzed intensively during the past decade. Investigation of the role of DCs during HCMV infection, however, has begun only recently. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  1999        PMID: 10702719     DOI: 10.1159/000053973

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  11 in total

1.  Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus.

Authors:  Laura Hertel; Vashti G Lacaille; Herbert Strobl; Elizabeth D Mellins; Edward S Mocarski
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

2.  Myeloid Dendritic Cells Repress Human Cytomegalovirus Gene Expression and Spread by Releasing Interferon-Unrelated Soluble Antiviral Factors.

Authors:  Bahram Kasmapour; Tobias Kubsch; Ulfert Rand; Britta Eiz-Vesper; Martin Messerle; Florian W R Vondran; Bettina Wiegmann; Axel Haverich; Luka Cicin-Sain
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

3.  Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.

Authors:  J Vaz-Santiago; J Lulé; P Rohrlich; C Jacquier; N Gibert; E Le Roy; D Betbeder; J L Davignon; C Davrinche
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

4.  Human cytomegalovirus gene products US2 and US11 differ in their ability to attack major histocompatibility class I heavy chains in dendritic cells.

Authors:  Armin Rehm; Arne Engelsberg; Domenico Tortorella; Ida J Körner; Insa Lehmann; Hidde L Ploegh; Uta E Höpken
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

5.  Roles of phosphatidylinositol 3-kinase and NF-kappaB in human cytomegalovirus-mediated monocyte diapedesis and adhesion: strategy for viral persistence.

Authors:  M Shane Smith; Elizabeth R Bivins-Smith; A Michael Tilley; Gretchen L Bentz; Gary Chan; Jessica Minard; Andrew D Yurochko
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

6.  Identification of a mouse cytomegalovirus gene selectively targeting CD86 expression on antigen-presenting cells.

Authors:  Andrea Loewendorf; Corinna Krüger; Eva Maria Borst; Markus Wagner; Ursula Just; Martin Messerle
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 7.  Viruses, dendritic cells and the lung.

Authors:  R S Peebles; B S Graham
Journal:  Respir Res       Date:  2001-06-27

Review 8.  Viral interference with functions of the cellular receptor tyrosine phosphatase CD45.

Authors:  Nadine Thiel; Jasmin Zischke; Endrit Elbasani; Penelope Kay-Fedorov; Martin Messerle
Journal:  Viruses       Date:  2015-03-23       Impact factor: 5.048

9.  Dendritic cells are susceptible to infection with wild-type adenovirus, inducing a differentiation arrest in precursor cells and inducing a strong T-cell stimulation.

Authors:  Tobias Kessler; Klaus Hamprecht; Tobias Feuchtinger; Gerhard Jahn
Journal:  J Gen Virol       Date:  2009-12-23       Impact factor: 3.891

Review 10.  Modulation of dendritic cell functions by viral IL-10 encoded by human cytomegalovirus.

Authors:  Selmir Avdic; Brian P McSharry; Barry Slobedman
Journal:  Front Microbiol       Date:  2014-07-04       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.